From: Mobile DNA and the TE-Thrust hypothesis: supporting evidence from the primates
TE generated trait | Gene affected | Gene function | TE responsible | Distributiona | Type of event | Effect | Tissue expression | Type of TE-Thrust | Reference |
---|---|---|---|---|---|---|---|---|---|
Soluble CD55 | CD55 | Complement regulation | Alu | >Human | Exonization | Novel isoform | Various | Active | Caras et al., 1987 [146] |
Intracellular TNFR | P75TNFR | Tumour necrosis factor receptor | Alu | Old World primate | Exonization | Novel isoform | Various | Active | Singer et al., 2004 [147] |
Altered infectious-disease resistance? | IRGM | Intracellular pathogen resistance | ERVb | Afr. Great Ape | Regulatory | Major promoter | Various | Active | Bekpen et al., 2009 [148] |
Altered infectious-disease resistance? | IL29 | Antiviral cytokine | Alu/LTRc | >Human | Regulatory | Positive regulation | Dendritic cells, epithelial cells | Active | Thomson et al., 2009 [149] |
 | FCER1G | IgE/IgG Fc receptor/T cell antigen receptor | Alu | Ape | Regulatory | Positive/negative regulation | T cells, basophils | Active | Brini et al., 1993 [150] |
 | CD8A | T cell interaction with class I MHC | Alu | Ape | Regulatory | Tissue-specific enhancer | T cells | Active | Hambor et al., 1993 [151] |
Red cell ABH antigen expression | FUT1 | Fucosyltransferase | Alu | Ape | Regulatory | Alternative promoter | Erythrocytes | Active | Apoil et al., 2000 [96] |
 | TMPRSS3 | Membrane serine protease | Alu/LTR | >Human | Regulatory | Alternative promoter | Peripheral blood leukocytes | Active | van de Lagemaat et al., 2003 [73] |
Colon Le antigen expression | B3GALT5 | Galactosyltransferase | ERV | Old World primate | Regulatory | Alternative promoter | Colon, small intestine, breast | Active | Dunn et al., 2003 [152] |
Prolactin potentiation of the adaptive immune response | PRL | Regulation of lactation and reproduction | ERV | Old World primate | Regulatory | Alternative promoter | Lymphocytes, endometrium | Active | Gerlo et al., 2006 [153] |
 | ST6GAL1 | Sialyltransferase | ERV | >Human | Regulatory | Alternative promoter | B lymphocytes | Active | van de Lagemaat et al., 2003 [73] |
Vitamin D regulation of cathelicidin antimicrobial peptide gene | CAMP | Antimicrobial peptide | Alu | Simian | Regulatory | Vitamin D responsiveness | Myeloid cells, various | Active | Gombart et al., 2009 [98] |
 | MPO | Myeloperoxidase/microbicidal enzyme | Alu | >Human | Regulatory | Thyroid hormone/retinoic acid responsiveness | Myeloid cells | Active | Piedrafita et al., 1996 [154] |
Altered infectious-disease resistance? | IFNG | Antiviral/immunoregulatory factor | Alu | Old World primate | Retrotransposition | Novel positive regulatory element | Natural killer cells, T cells | Active | Ackerman et al., 2002 [155] |
Absence of N-glycolylneuraminic acid/altered infectious-disease resistance? | CMAH | N-glycolylneuraminic acid synthesis | Alu | Human | Gene disruption | Gene loss | Various | Active | Hayakawa et al., 2001 [104] |
 | IRGM | Intracellular pathogen resistance | Alu | Old and New World monkey | Gene disruption | Gene loss | Various | Active | Bekpen et al., 2009 [148] |
Altered malaria resistance? | HBA2 | Oxygen transport | Alu | >Ape | Duplication | Novel gene | Erythrocytes | Passive | Hess et al., 1983 [156] |